本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

0.2779
-0.1121-28.74%
盤前0.2650-0.0129-4.64%06:19 EST
成交量:190.43萬
成交額:56.34萬
市值:371.39萬
市盈率:-0.06
高:0.3495
開:0.3401
低:0.2570
收:0.3900
52周最高:11.00
52周最低:0.0002
股本:1,336.42萬
流通股本:340.45萬
量比:1.55
換手率:55.93%
股息:- -
股息率:- -
每股收益(TTM):-4.9510
每股收益(LYR):-14.8490
淨資產收益率:-1236.83%
總資產收益率:-427.27%
市淨率:0.26
市盈率(LYR):-0.02

資料載入中...

2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/12

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/06

重要事件披露

Form 8-K - Current report
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/09/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/30

重要事件披露

Form 8-K - Current report